Ipsen is a global pharmaceutical company dedicated to prolonging patients' lives, improving health outcomes, and creating a positive impact for patients and society. With a team of over 5,000 talented professionals worldwide, Ipsen works tirelessly to innovate for the benefit of patients and caregivers. Their purpose-led people are passionate about making a real impact on patients' lives each day by discovering, innovating, and bringing to market pharmaceutical products that make a difference.

As a global mid-size biopharmaceutical company, Ipsen focuses on transformative medicines in oncology, rare disease, and neuroscience. Their strategy, Focus. Together.

For patients & society, guides their decision-making process. Ipsen is committed to ensuring patient access to their treatments, building a sustainable pipeline for innovative therapies, delivering efficiencies to support growth, and fostering a culture of collaboration and excellence. Striving to make a meaningful difference, Ipsen operates across four key areas: Environment, Patients, People, and Governance.

With their global reach and agile approach, Ipsen's products are registered in over 100 countries. They have a clear mission and responsibility to improve the lives of people with serious diseases and are dedicated to growing and innovating for their patients for years to come